Basic Information
ID: ALA5259664
Type: Functional
Description: Anti-hepatic fibrosis activity in human LX2 cells assessed as inhibition of COL1A1 promoter activity at 25 micromol/L by luciferase reporter assay relative to control
Organism: Homo sapiens
Cell type: LX-2
Activity Charts
Bioactivity
Activity Types for Assay ALA5259664
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 458.38 | 2.23 | 2.23 |
| 232.32 | 3.55 | 3.55 |
| 420.63 | 5.11 | 5.11 |
| 523.75 | 6.72 | 6.72 |
| 509.76 | 7.08 | 7.08 |
| 509.76 | 7.08 | 7.08 |
| 435.86 | 4.80 | 4.80 |
| 452.32 | 5.31 | 5.31 |
| 435.86 | 4.80 | 4.80 |
| 486.76 | 5.97 | 5.97 |
| 466.30 | 4.95 | 4.95 |
| 525.76 | 6.96 | 6.96 |
| 481.32 | 5.35 | 5.35 |
| 525.76 | 6.96 | 6.96 |
| 413.46 | 4.02 | 4.02 |
| 510.45 | 5.07 | 5.07 |
| 471.79 | 6.07 | 6.07 |
| 466.30 | 4.95 | 4.95 |
| 427.44 | 3.66 | 3.66 |
| 397.46 | 4.32 | 4.32 |
| 466.30 | 4.95 | 4.95 |
| 452.32 | 5.31 | 5.31 |
| 481.32 | 5.35 | 5.35 |
| 471.79 | 6.07 | 6.07 |
| 446.87 | 4.69 | 4.69 |
| 500.75 | 5.61 | 5.61 |
| 520.32 | 6.34 | 6.34 |
| 446.87 | 4.69 | 4.69 |
| 486.76 | 5.97 | 5.97 |
| 480.42 | 5.06 | 5.06 |
| 466.30 | 4.95 | 4.95 |
| 500.79 | 6.10 | 6.10 |
| 481.32 | 5.35 | 5.35 |
| 500.75 | 5.61 | 5.61 |
| 476.21 | 6.71 | 6.71 |
| 435.86 | 4.80 | 4.80 |
| 514.87 | 5.71 | 5.71 |
| 442.45 | 4.05 | 4.05 |
| 481.32 | 5.35 | 5.35 |
| 485.78 | 5.71 | 5.71 |
| 469.78 | 6.01 | 6.01 |
| 514.87 | 5.71 | 5.71 |
| 480.42 | 5.06 | 5.06 |
| 466.30 | 4.95 | 4.95 |
| 476.21 | 6.71 | 6.71 |
| 480.42 | 5.06 | 5.06 |
| 484.79 | 6.40 | 6.40 |
| 466.30 | 4.95 | 4.95 |
| 480.42 | 5.06 | 5.06 |
| 510.45 | 5.07 | 5.07 |
| 455.79 | 6.37 | 6.37 |
| 449.85 | 4.44 | 4.44 |
| 455.79 | 6.37 | 6.37 |
| 435.86 | 4.80 | 4.80 |
| 442.45 | 4.05 | 4.05 |
| 500.75 | 5.61 | 5.61 |